Vibration‐controlled transient elastography in pediatric metabolic dysfunction‐associated steatotic liver disease
Journal of Pediatric Gastroenterology and Nutrition · 2026
DOI: 10.1002/jpn3.70284 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2026. Verfasst von Lauren B Nichols und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of California San Diego School of Medicine, La Jolla, C…. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Center for Advancing Translational Sciences (NCATS), NIDDK NIH HHS.
Abstract (Originalsprache)
Objectives
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a prevalent disease in children. Vibration‐controlled transient elastography (VCTE) offers a noninvasive alternative to liver biopsy, using controlled attenuation parameter (CAP) to estimate steatosis and liver stiffness measurement (LSM) for fibrosis. However, pediatric data with histological validation are limited. This prospective, multicenter study evaluated the accuracy of CAP and LSM in pediatric MASLD.
Methods
Children with histologically confirmed MASLD from the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Database 3 underwent VCTE within 6 months of liver biopsy. CAP was evaluated for correlation with steatosis grades, and LSM for correlation with fibrosis stages. The diagnostic performance of LSM in distinguishing fibrosis stages was analyzed using histological findings as the reference standard.
Results
Among 92 children with MASLD (mean age 13 ± 3 years), CAP values were similar across steatosis grades (median 325, 310, and 323 dB/m for grades 1–3, respectively) and showed no significant correlation with histologic steatosis ( p = 0.422). Median LSM values increased with fibrosis stage (6.0–8.8 kPa), but significant differences were detected only between stage 0 and stage 3 fibrosis ( p = 0.037). For advanced fibrosis (stages 3–4), area under the receiver operating characteristic curve was 0.67, with sensitivity 67%, specificity 76%, positive predictive value 40%, and negative predictive value 90%.
Conclusion
In this prospective, multicenter cohort, VCTE showed modest accuracy for grading steatosis or staging fibrosis in pediatric MASLD. Improved noninvasive methods are urgently needed for evaluation and monitoring in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of California San Diego School of Medicine, La Jolla, California, USA.
- Department of Gastroenterology, Rady Children's Hospital, San Diego, California, USA.
- Earl Warren College, University of California San Diego, La Jolla, California, USA.
- Department of Pediatrics, Riley Children's Hospital, Indianapolis, Indiana, USA.
- Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Department of Pediatrics, Texas Children's Hospital, Houston, Texas, USA.
ORCID-Profile: Lauren B Nichols, Sebastian G J Oakes, Cynthia Behling, Kathryn Harlow Adams, Mark H Fishbein, Paula Hertel, Chao Jarasvaraparn, Jean P Molleston, Marialena Mouzaki, Claude B Sirlin, Miriam B Vos, Laura A Wilson, Stavra A Xanthakos, Jeffrey B Schwimmer
Förderung
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Center for Advancing Translational Sciences (NCATS)
- NIDDK NIH HHS
- NCATS NIH HHS
- Intramural Division of the National Cancer Institute (NCI)
Zitieren
APA
Nichols, L. B., Oakes, S. G. J., Behling, C., Adams, K. H., Fishbein, M. H., Hertel, P., Jarasvaraparn, C., Molleston, J. P., Mouzaki, M., Sirlin, C. B., Vos, M. B., Wilson, L. A., Xanthakos, S. A., Schwimmer, J. B., & NASH CRN (2026). Vibration‐controlled transient elastography in pediatric metabolic dysfunction‐associated steatotic liver disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70284
Vancouver
Nichols LB, Oakes SGJ, Behling C, Adams KH, Fishbein MH, Hertel P, et al. Vibration‐controlled transient elastography in pediatric metabolic dysfunction‐associated steatotic liver disease. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70284
BibTeX
@article{Nichols2026,
author = {Nichols, Lauren B and Oakes, Sebastian G J and Behling, Cynthia and Adams, Kathryn Harlow and Fishbein, Mark H and Hertel, Paula and Jarasvaraparn, Chao and Molleston, Jean P and Mouzaki, Marialena and Sirlin, Claude B and Vos, Miriam B and Wilson, Laura A and Xanthakos, Stavra A and Schwimmer, Jeffrey B and NASH CRN, NASH CRN},
title = {Vibration‐controlled transient elastography in pediatric metabolic dysfunction‐associated steatotic liver disease},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2026},
doi = {10.1002/jpn3.70284}
}
EUVIMED